Dipna Pharmachem submits intimation of in-principle approval for rights issue

18 Jan 2024 Evaluate
Dipna Pharmachem has informed that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, the exchange has issued In-principle approval vide Ref: LOD/RIGHT/CP/FIP/1109/2023-24 dated 17th January, 2024 for the proposed rights issue. The In-principle approval letter received from the Stock Exchange i.e. BSE is enclosed.

The above information is a part of company’s filings submitted to BSE.

Dipna Pharma. Share Price

15.00 -0.99 (-6.19%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Redington 268.50
Adani Enterprises 2265.10
Amrapali Industries 15.02
Rashi Peripheral 325.05
PDS 339.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×